Bucki Bogusław, Tomaszewska Renata, Karpe Jacek, Stoksik Piotr, Sońta-Jakimczyk Danuta, Szczepański Tomasz
Department of Emergency Medicine, Bytom, Medical University of Silesia, Katowice, Poland.
Pediatr Hematol Oncol. 2008 Dec;25(8):751-5. doi: 10.1080/08880010802313632.
During past 10 years 234 central venous access ports (CVAP) were implanted in 225 patients at the Department of Pediatric Hematology and Oncology in Zabrze. Mean exposure time was 745 days and total implantation time reached 173,768 days. Complications were encountered in 17 patients (7.6%). This mainly concerned central venous line infection, which led to removal of 10 CVAP (4.4%). The remaining complications necessitating removal of the CVAP consisted mainly of mechanical problems (catheter fracture, occlusion, and erroneous implantation to artery). In the opinion of the authors, subcutaneously implanted CVAP are a safe and effective option for high-dose chemotherapy deliverance in childhood cancer patients.
在过去10年里，扎布热儿科血液学和肿瘤学系为225名患者植入了234个中心静脉通路端口（CVAP）。平均暴露时间为745天，总植入时间达173768天。17名患者（7.6%）出现并发症。这主要涉及中心静脉导管感染，导致10个CVAP被移除（4.4%）。其余需要移除CVAP的并发症主要是机械问题（导管断裂、堵塞以及误植入动脉）。作者认为，皮下植入CVAP是儿童癌症患者进行高剂量化疗的一种安全有效的选择。
